Skip to main content
Clinical Trials/NL-OMON31251
NL-OMON31251
Recruiting
Not Applicable

se of a real time continuous glucose monitoring system (RT-CGMS) in type 1 diabetes patients on continuous intraperitoneal insulin infusion (CIPII). A feasibility study. - RT-CGMS in CIPII / IP-SENSOR study

Isala Klinieken0 sites12 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
diabetes
Sponsor
Isala Klinieken
Enrollment
12
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Isala Klinieken

Eligibility Criteria

Inclusion Criteria

  • Patients on CIPII and treated in the Isala Clinic, Zwolle, The Netherlands.
  • Age \>18 years
  • Uncontrolled diabetes mellitus type 1; HbA1c at last measurement (not longer than 6 weeks ago) \>7\.5% and/or \>5 hypoglycaemic events /week as measured by SMBG.

Exclusion Criteria

  • Failure to obtain informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials